135 related articles for article (PubMed ID: 9500866)
1. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.
Kilgore KS; Park JL; Tanhehco EJ; Booth EA; Marks RM; Lucchesi BR
J Mol Cell Cardiol; 1998 Jan; 30(1):75-85. PubMed ID: 9500866
[TBL] [Abstract][Full Text] [Related]
2. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis.
Tramontini N; Huber C; Liu-Bryan R; Terkeltaub RA; Kilgore KS
Arthritis Rheum; 2004 Aug; 50(8):2633-9. PubMed ID: 15334478
[TBL] [Abstract][Full Text] [Related]
3. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
4. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.
Kilgore KS; Flory CM; Miller BF; Evans VM; Warren JS
Am J Pathol; 1996 Sep; 149(3):953-61. PubMed ID: 8780399
[TBL] [Abstract][Full Text] [Related]
5. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Vinten-Johansen J
Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidence for a border zone vulnerable to inflammatory reperfusion injury.
Youker KA; Hawkins HK; Kukielka GL; Perrard JL; Michael LH; Ballantyne CM; Smith CW; Entman ML
Trans Assoc Am Physicians; 1993; 106():145-54. PubMed ID: 7913564
[TBL] [Abstract][Full Text] [Related]
7. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.
Oyama J; Blais C; Liu X; Pu M; Kobzik L; Kelly RA; Bourcier T
Circulation; 2004 Feb; 109(6):784-9. PubMed ID: 14970116
[TBL] [Abstract][Full Text] [Related]
8. Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics.
Kilgore KS; Tanhehco EJ; Park JL; Naylor KB; Anderson MB; Lucchesi BR
J Pharmacol Exp Ther; 1998 Jan; 284(1):427-35. PubMed ID: 9435207
[TBL] [Abstract][Full Text] [Related]
9. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits.
Ito W; Schäfer HJ; Bhakdi S; Klask R; Hansen S; Schaarschmidt S; Schofer J; Hugo F; Hamdoch T; Mathey D
Cardiovasc Res; 1996 Aug; 32(2):294-305. PubMed ID: 8796116
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylheparin pretreatment reduces infarct size in the rabbit.
Park JL; Kilgore KS; Naylor KB; Booth EA; Murphy KL; Lucchesi BR
Pharmacology; 1999 Mar; 58(3):120-31. PubMed ID: 9925968
[TBL] [Abstract][Full Text] [Related]
11. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
Buerke M; Prüfer D; Dahm M; Oelert H; Meyer J; Darius H
J Pharmacol Exp Ther; 1998 Jul; 286(1):429-38. PubMed ID: 9655888
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
13. Complement, neutrophils and free radicals: mediators of reperfusion injury.
Lucchesi BR
Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
Tarzami ST; Miao W; Mani K; Lopez L; Factor SM; Berman JW; Kitsis RN
Circulation; 2003 Nov; 108(19):2387-92. PubMed ID: 14568904
[TBL] [Abstract][Full Text] [Related]
15. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on.
Baxter GF
Basic Res Cardiol; 2002 Jul; 97(4):268-75. PubMed ID: 12111036
[TBL] [Abstract][Full Text] [Related]
16. The role of natural IgM in myocardial ischemia-reperfusion injury.
Zhang M; Michael LH; Grosjean SA; Kelly RA; Carroll MC; Entman ML
J Mol Cell Cardiol; 2006 Jul; 41(1):62-7. PubMed ID: 16781728
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.
Squadrito F; Altavilla D; Squadrito G; Saitta A; Deodato B; Arlotta M; Minutoli L; Quartarone C; Ferlito M; Caputi AP
J Mol Cell Cardiol; 2000 Mar; 32(3):429-40. PubMed ID: 10731442
[TBL] [Abstract][Full Text] [Related]
18. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
[TBL] [Abstract][Full Text] [Related]
19. Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.
Tramontini NL; Kuipers PJ; Huber CM; Murphy K; Naylor KB; Broady AJ; Kilgore KS
Inflammation; 2002 Dec; 26(6):311-9. PubMed ID: 12546141
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
